THERAPEUTIC CLASS

The spectrum of kidney biopsy findings in patients with morbid obesity

---

Morbid obesity, defined as bodymass index (BMI) ‡40 kg/m2, affects approximately 8% of United States adults and is a
recognized risk factor for chronic kidney disease (CKD). We present the first focused biopsy-based study exploring the
range of kidney diseases in this population. Among 3263 native kidney biopsies interpreted at Columbia University in
2017, we identified 248 biopsies from morbidly obese patients.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Genito-urinary System

Specific Detail Info

Kidney International (2019)

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment